Cipla moves up on the bourses

15 Jun 2018 Evaluate

Cipla is currently trading at Rs. 604.75, up by 16.80 points or 2.86% from its previous closing of Rs. 587.95 on the BSE.

The scrip opened at Rs. 592.50 and has touched a high and low of Rs. 609.65 and Rs. 590.15 respectively. So far 158542 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 663.00 on 07-Nov-2017 and a 52 week low of Rs. 508.10 on 22-May-2018.

Last one week high and low of the scrip stood at Rs. 609.65 and Rs. 558.10 respectively. The current market cap of the company is Rs. 48715.01 crore.

The promoters holding in the company stood at 37.21%, while Institutions and Non-Institutions held 38.10% and 24.69% respectively.

Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, single-use sterile Ampoule from the United States Food and Drug Administration (US FDA). The company's Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, ampoule is APrated generic therapeutic equivalent version of Hospira Inc’s Isuprel Injection, 0.2mg/ml.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1433.40 -14.20 (-0.98%)
14-Jan-2026 14:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.00
Dr. Reddys Lab 1185.25
Cipla 1433.40
Zydus Lifesciences 884.00
Lupin 2198.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×